Medicinehospital

Golimumab

An injectable TNF-blocker for inflammatory arthritis, ankylosing spondylitis and ulcerative colitis.

Clinical information

Common uses

rheumatoid arthritis (with methotrexate)
psoriatic arthritis
ankylosing spondylitis
ulcerative colitis

Common side effects

upper respiratory tract infection
cold-like symptoms (nasopharyngitis)
injection site reactions

Cautions

boxed warning: serious infections including tuberculosis — TB test needed first
boxed warning: lymphoma and other cancers reported with TNF blockers
can cause new or worsening heart failure
can reactivate hepatitis B

Interactions

abatacept — increased risk of serious infection
anakinra — increased risk of serious infection
live vaccines — avoid

Pregnancy: crosses the placenta late in pregnancy — talk to your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Simponi (golimumab) label, setid f86cb4a7-c358-4136-ae57-b32bda9bba00 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Golimumab	Parenteral ( pre-filled syringe injection)	50 mg/ 0.5 ml	MFDA designated importers with Pre Authorization approval before import	hospital